The Adaptate Biotherapeutics brand, founded in 2019 (Canada), from 440 sister brands and 4958 competing brands. The Adaptate Biotherapeutics brand is owned by Takeda Pharmaceutical, a company listed in Francfort. The International Securities Identification Number (ISIN) of Takeda Pharmaceutical is JP3463000004. Adaptate Biotherapeutics is part of the Drug Manufacturers activity sector.
Investment simulator :
Portfolio valuation
Takeda Pharmaceutical
(Adaptate Biotherapeutics)
over 5 years*
EUR 18.51